Crossmark

FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21

Crossref DOI link: https://doi.org/10.1186/s13046-019-1058-6

Published Online: 2019-02-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Long

Chen, Jin

Ning, Deng

Liu, Qiumeng

Wang, Chao

Zhang, Zhaoqi

Chu, Liang

Yu, Chengpeng

Liang, Hui-fang

Zhang, Bixiang

Chen, Xiaoping
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31671348, 81572855, 81572427)

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2018ZX10723204-003)

Natural Science Foundation of Hubei Province (2015CFB462)

National Natural Science Foundation of China (81874189)
License Information

Text and Data Mining valid from 2019-02-26
More Information

Article History

Received: 5 November 2018

Accepted: 27 January 2019

First Online: 26 February 2019

Ethics approval and consent to participate

: All procedures performed in this study involving human participants and animals were approved by the Ethics Committee of Tongji Hospital. Signed informed consent was obtained from each patient.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.